Fertility preservation techniques in cervical carcinoma. Issue 17 (29th April 2022)

• Record Type: Journal Article
• Authors: Silvestris, Erica; Paradiso, Angelo Virgilio; Minoia, Carla; Daniele, Antonella; Cormio, Gennaro; Tinelli, Raffaele; D'Oronzo, Stella; Cafforio, Paola; Loizzi, Vera; Dellino, Miriam
• Editors: Saranathan., Maya
• Is Part Of: Medicine. Volume 101:Issue 17(2022)
• Page Start: e29163
• Publication Date: 2022-04-29
• Subjects: cancer -- cryopreservation -- fertility preservation -- in vitro fertilization -- ovarian stem cells; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000029163
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Astract: The usefulness of this review is to highlight how a fertility preservation (FP) approach is currently feasible for patients diagnosed with uterine cervical cancer. To this regard, a fertility sparing surgery has just overcome its traditional limits, gained acceptance within the major gynecologic oncology societies thanks to the ability to identify the "ideal" candidates to this conservative treatment. On the other hand, the use of other FPs for oocyte and ovarian cortex cryopreservation is still extremely debated. In fact, the existing risk of tumor spreading during oocyte retrieval necessary for oocyte cryostorage for patients' candidates for neo-adjuvant therapy, as well as the potential hazard of cancer cell dissemination after ovarian tissue replacement in cases of non-squamous type cervical carcinomas should not be underestimated. Therefore, in consideration of the encountered limitations and the need to ensure adequate reproductive health for young uterine cervical cancer survivors, translational research regarding the FP has progressively collected innovative insights into the employment of stemness technology. In this context, the property of ovarian stem cells obtained from the ovarian cortex to generate functional oocytes in women could represent a promising therapeutic alternative to the current procedures for a novel and safer FP approach in cancer survivors.